The systems in place to enable compliance with the requirements of the Food Drug and Cosmetic Act Section 582 (c) are deficient: a.
Inspection Record
McKesson Corporation — FDA 483 Findings
Inspectors Jolanna A. NortonThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Failure to make a determination regarding product subject to an illegitimate product notification from a trading partner.
Systems and procedures to make notifications following determination of an illegitimate product are deficient in that they do not instruct notifications to all immediate trading partners, and sufficient tracing information is not retained to identify trading partners that received such product.
A record as of the US FDA document published on 2019-04-30. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.